| Cynthia Marie Eisenbeis, MSW, LCSW | |
|
223 N Main St, Suite #3, Saint Charles, MO 63301-2828 | |
| (314) 484-6198 | |
| Not Available |
| Full Name | Cynthia Marie Eisenbeis |
|---|---|
| Gender | Female |
| Speciality | Clinical Social Worker |
| Experience | 23 Years |
| Location | 223 N Main St, Saint Charles, Missouri |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1205883550 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 1041C0700X | Social Worker - Clinical | 2005040010 (Missouri) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Main Street Counseling, Llc | 2062598600 | 7 |
News Archive
TGen Drug Development (TD2) is poised to play a significant role in the expansion of Scottsdale's biomedical industry, fostering new jobs and city revenues, and prompting the creation of more related businesses.
Results from a recent preclinical study have shown that a new drug combination therapy being developed at Virginia Commonwealth University Massey Cancer Center effectively killed colon, liver, lung, kidney, breast and brain cancer cells while having little effect on noncancerous cells. The results lay the foundation for researchers to plan a future phase 1 clinical trial to test the safety of the therapy in a small group of patients.
Hypertension is a common medical condition and a primary cause of cardiovascular diseases and stroke worldwide.
Screening a class of recently-developed drug compounds - so-called "CDK inhibitors" capable of blocking CDK7/12/13 proteins - against hundreds of different human cancer cell lines, researchers at Dana-Farber/Boston Children's Cancer and Blood Disorders Center have found that CDK12 inhibitors pack a particularly lethal punch to Ewing sarcoma, a rare cancer typically affecting children and young adults.
› Verified 5 days ago
| Entity Name | Main Street Counseling, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1710158704 PECOS PAC ID: 2062598600 Enrollment ID: O20080325000008 |
News Archive
TGen Drug Development (TD2) is poised to play a significant role in the expansion of Scottsdale's biomedical industry, fostering new jobs and city revenues, and prompting the creation of more related businesses.
Results from a recent preclinical study have shown that a new drug combination therapy being developed at Virginia Commonwealth University Massey Cancer Center effectively killed colon, liver, lung, kidney, breast and brain cancer cells while having little effect on noncancerous cells. The results lay the foundation for researchers to plan a future phase 1 clinical trial to test the safety of the therapy in a small group of patients.
Hypertension is a common medical condition and a primary cause of cardiovascular diseases and stroke worldwide.
Screening a class of recently-developed drug compounds - so-called "CDK inhibitors" capable of blocking CDK7/12/13 proteins - against hundreds of different human cancer cell lines, researchers at Dana-Farber/Boston Children's Cancer and Blood Disorders Center have found that CDK12 inhibitors pack a particularly lethal punch to Ewing sarcoma, a rare cancer typically affecting children and young adults.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Cynthia Marie Eisenbeis, MSW, LCSW 621 Bull Valley Dr, Saint Peters, MO 63304-8544 Ph: (314) 484-6198 | Cynthia Marie Eisenbeis, MSW, LCSW 223 N Main St, Suite #3, Saint Charles, MO 63301-2828 Ph: (314) 484-6198 |
News Archive
TGen Drug Development (TD2) is poised to play a significant role in the expansion of Scottsdale's biomedical industry, fostering new jobs and city revenues, and prompting the creation of more related businesses.
Results from a recent preclinical study have shown that a new drug combination therapy being developed at Virginia Commonwealth University Massey Cancer Center effectively killed colon, liver, lung, kidney, breast and brain cancer cells while having little effect on noncancerous cells. The results lay the foundation for researchers to plan a future phase 1 clinical trial to test the safety of the therapy in a small group of patients.
Hypertension is a common medical condition and a primary cause of cardiovascular diseases and stroke worldwide.
Screening a class of recently-developed drug compounds - so-called "CDK inhibitors" capable of blocking CDK7/12/13 proteins - against hundreds of different human cancer cell lines, researchers at Dana-Farber/Boston Children's Cancer and Blood Disorders Center have found that CDK12 inhibitors pack a particularly lethal punch to Ewing sarcoma, a rare cancer typically affecting children and young adults.
› Verified 5 days ago
Mrs. Stephanie Lynch Reh, LCSW Clinical Social Worker Medicare: Medicare Enrolled Practice Location: 102 Compass Point Dr, Saint Charles, MO 63301 Phone: 888-403-1071 | |
Thelma L Conley, LCSW Clinical Social Worker Medicare: Medicare Enrolled Practice Location: 102 Compass Point Dr, Saint Charles, MO 63301 Phone: 636-946-4000 | |
Dianne Dodge, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 1428 Hudson Lndg, Saint Charles, MO 63303 Phone: 314-302-7999 | |
Ellen M Burkemper, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 102 Compass Point Dr, Saint Charles, MO 63301 Phone: 636-946-4000 | |
Jacqueline Barnes, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 2536 S Old Highway 94, Suite 222, Saint Charles, MO 63303 Phone: 636-447-4198 | |
Mrs. Petina Collier Lindsey, LCSW Clinical Social Worker Medicare: Medicare Enrolled Practice Location: 2536 S Old Highway 94, Ste 220, Saint Charles, MO 63303 Phone: 314-322-3326 Fax: 636-329-0934 | |
Ms. Julie Michelle Wiechens, M.S.W., L.C.S.W Clinical Social Worker Medicare: Accepting Medicare Assignments Practice Location: 2440 Executive Dr, Suite 210, Saint Charles, MO 63303 Phone: 636-447-1902 Fax: 636-447-1902 |